Global Bio-chem Technology Group Company Limited (HKG:0809)
0.0570
0.00 (0.00%)
Apr 29, 2026, 2:54 PM HKT
HKG:0809 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 2,279 | 2,001 | 1,374 | 12.71 | 746.55 | Upgrade
|
| Revenue Growth (YoY) | 13.86% | 45.65% | 10709.05% | -98.30% | -12.05% | Upgrade
|
| Cost of Revenue | 2,082 | 1,782 | 1,330 | 4.82 | 721.29 | Upgrade
|
| Gross Profit | 196.44 | 218.68 | 43.64 | 7.89 | 25.26 | Upgrade
|
| Selling, General & Admin | 305.66 | 354.29 | 370.15 | 267.51 | 399.75 | Upgrade
|
| Other Operating Expenses | 138.39 | - | - | 496.39 | 571.34 | Upgrade
|
| Operating Expenses | 444.05 | 354.29 | 370.15 | 763.89 | 971.09 | Upgrade
|
| Operating Income | -247.61 | -135.61 | -326.52 | -756.01 | -945.83 | Upgrade
|
| Interest Expense | -308.11 | -323.4 | -750.35 | -685.18 | -831.69 | Upgrade
|
| Interest & Investment Income | 0.01 | 0 | 0 | 0.02 | 0.27 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -2 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.01 | 4.52 | - | - | 1.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 51.23 | -67.38 | -237.56 | 16.22 | 80.19 | Upgrade
|
| EBT Excluding Unusual Items | -501.47 | -521.87 | -1,314 | -1,425 | -1,698 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 14.1 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 14.2 | 1,962 | 421.87 | - | - | Upgrade
|
| Asset Writedown | -68.31 | -776.12 | 7.41 | - | -36.46 | Upgrade
|
| Other Unusual Items | 711.99 | 67.39 | 4,586 | - | 1,325 | Upgrade
|
| Pretax Income | 156.41 | 745.62 | 3,701 | -1,425 | -409.47 | Upgrade
|
| Income Tax Expense | 0.11 | -23.98 | -42.08 | -46.79 | 25.92 | Upgrade
|
| Earnings From Continuing Operations | 156.3 | 769.6 | 3,743 | -1,378 | -435.39 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 481.47 | -141.41 | - | Upgrade
|
| Net Income to Company | 156.3 | 769.6 | 4,225 | -1,520 | -435.39 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 76.5 | 34.59 | Upgrade
|
| Net Income | 156.3 | 769.6 | 4,225 | -1,443 | -400.8 | Upgrade
|
| Net Income to Common | 156.3 | 769.6 | 4,225 | -1,443 | -400.8 | Upgrade
|
| Net Income Growth | -79.69% | -81.78% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 10,818 | 8,929 | 8,907 | 8,907 | 8,907 | Upgrade
|
| Shares Outstanding (Diluted) | 28,086 | 26,196 | 14,080 | 8,907 | 8,907 | Upgrade
|
| Shares Change (YoY) | 7.21% | 86.05% | 58.07% | - | 4.70% | Upgrade
|
| EPS (Basic) | 0.01 | 0.09 | 0.47 | -0.16 | -0.04 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.03 | 0.29 | -0.16 | -0.04 | Upgrade
|
| EPS Growth | -79.31% | -90.02% | - | - | - | Upgrade
|
| Free Cash Flow | - | 76.04 | -94.24 | -94.19 | -501.02 | Upgrade
|
| Free Cash Flow Per Share | - | 0.00 | -0.01 | -0.01 | -0.06 | Upgrade
|
| Gross Margin | 8.62% | 10.93% | 3.18% | 62.06% | 3.38% | Upgrade
|
| Operating Margin | -10.87% | -6.78% | -23.77% | -5947.64% | -126.69% | Upgrade
|
| Profit Margin | 6.86% | 38.46% | 307.48% | -11352.91% | -53.69% | Upgrade
|
| Free Cash Flow Margin | - | 3.80% | -6.86% | -740.98% | -67.11% | Upgrade
|
| EBITDA | -34.95 | 77.05 | -43.5 | -447.63 | -567.57 | Upgrade
|
| EBITDA Margin | -1.53% | 3.85% | -3.17% | - | -76.03% | Upgrade
|
| D&A For EBITDA | 212.66 | 212.66 | 283.02 | 308.37 | 378.26 | Upgrade
|
| EBIT | -247.61 | -135.61 | -326.52 | -756.01 | -945.83 | Upgrade
|
| EBIT Margin | -10.87% | -6.78% | -23.77% | - | -126.69% | Upgrade
|
| Effective Tax Rate | 0.07% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.